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Introduction: The purpose of this experimental study was to 
compare the relationship of Ktrans from DCE-MRI and K1 from 
dynamic 13N-NH3-PET between simultaneous and separate 
MR/PET acquisition in the VX2 rabbit carcinoma model. 
Methods: Eight rabbits underwent MR/PET examination 
simultaneously and separately, 14 and 15 days after VX2 tumor 
implantation at the left paravertebral muscle. The Ktrans and K1 
values were estimated using an in-house software program. The 
 
 ii 
relationships between Ktrans and K1 were analyzed using Pearson’s 
correlation coefficients and linear/nonlinear regression function. 
Results: This study finally included five rabbits. Assuming a linear 
relationship, Ktrans and K1 exhibited moderate positive correlations 
with both simultaneous (r = 0.54–0.57) and separate (r = 0.53–
0.69) imaging. However, while the Ktrans and K1 from separate 
imaging were linearly correlated, those from simultaneous imaging 
exhibited a nonlinear relationship. The amount of change in K1 
associated with a unit increase in Ktrans varied depending on Ktrans 
values. 
Conclusions: The relationship between Ktrans and K1 was different 
between simultaneous and separate MR/PET acquisition. The 
relationship between Ktrans and K1 may be mis-interpreted with 
separate MR and PET acquisition. 
------------------------------------- 
Keywords: MR/PET, dynamic contrast enhanced-MRI, 13N-NH3 
PET, perfusion parameter, rabbit 




Table of Contents    
INTRODUCTION ...................................................................... １ 
MATERIALS AND METHODS ................................................. ３ 
RESULTS................................................................................. 18 
DISCUSSION ........................................................................... 34 
REFERENCES .......................................................................... 39 






List of Tables 
Table 1. Summary of tumor characteristics in five rabbits ..... 22 
Table 2. Size of the whole tumor and necrotic area with the 
simultaneous and separate image acquisition in five rabbits ... 23 
Table 3. Goodness-of-fit parameters of the 1-tissue 
compartment model (1TCM) and 2-tissue compartment model 
(2TCM) in 13N-NH3 PET ........................................................ 25 
Table 4. Correlation coefficient between Ktrans and K1 with 
simultaneous scan and separate scan ...................................... 26 
Table 5. Reproducibility of Ktrans and K1 on ROI-level between 
two successive days ................................................................ 33 
 
List of Figure 
Figure 1. Schematic drawing of the MR/PET acquisition 
protocol. .................................................................................... ７ 
Figure 2. An example of the ultrasonographic images. ........... 19 
Figure 3. An example of the MR and PET images. .................. 20 
Figure 4. Parameteric maps of Ktrans and K1. ........................... 24 
Figure 5. Scatterplot of Ktrans versus K1 (K1 was calculated 
 
 v 
using 1TCM). ........................................................................... 30 
Figure 6. Scatterplot of Ktrans versus K1 (K1 was calculated 





With the recently introduced hybrid MR/PET machine, MR 
and PET images can be obtained simultaneously with perfect 
temporal and much improved spatial co-registration (1-3). MR 
imaging has high spatial resolution, high contrast resolution and 
enables diverse functional imaging while PET imaging can visualize 
molecular functional information including metabolic activity. With 
hybrid MR/PET machine, these advantages of MR and PET imaging 
can be combined to enable better assessment of physiologic and 
pathologic state in vivo with much improved workflow efficiency. 
Moreover, the simultaneity of hybrid MR/PET systems offers 
several advantages over separate MR and PET and PET/computed 
tomography (CT) (4, 5), including precise patient alignment, 
recording of dynamic phenomena, tissue information under identical 
physiologic state from both modalities, and better localization of 
PET signals in soft tissues (6). In terms of patient alignment, a 
previous study reported better alignment quality with simultaneous 
MR/PET than with retrospective fusion of MR and PET data (7). 
However, there has been no study that evaluated the simultaneity of 
hybrid MR/PET systems based on functional information. 
 
 ２ 
Dynamic contrast-enhanced magnetic resonance imaging 
(DCE-MRI) perfusion parameters are widely used for assessment 
of treatment response to anti-angiogenic drugs in both preclinical 
studies and clinical trials (8, 9). The main advantages of DCE-MRI 
are its high spatial resolution and nonuse of ionizing radiation (10, 
11). However, absolute quantification of flow is difficult because 
there is no linear relationship between signal intensity and 
gadolinium (Gd) concentration, and interpretation of DCE-MRI 
perfusion parameter is complicated. The transfer constant, Ktrans, 
has several physiologic interpretations, depending on the balance 
between capillary permeability and blood flow in the tissue of 
interest. On the other hand, dynamic 13N-NH3 positron emission 
tomography (PET) perfusion parameter, K1, is more 
straightforward, because K1 primarily reflects blood flow owing to 
high extraction fraction of 13N-NH3 (12, 13). Clarifying the 
relationship between Ktrans and K1 might enhance our understanding 
of tumor angiogenesis and vascular permeability (14). While 
dynamic 13N-NH3 PET has been clinically utilized in myocardial 
perfusion imaging (12, 13), its utility in tumor imaging is under-
investigated. However, several reports involving this technique 
have demonstrated promising results (15-18) in the diagnosis of 
 
 ３ 
brain tumors and fibrosarcomas using qualitative or semi-
quantitative analysis.  
The purpose of this study was to compare the relationship 
of Ktrans from DCE-MRI and K1 from dynamic 
13N-NH3-PET 
between simultaneous and separate MR/PET acquisition in the VX2 
rabbit carcinoma model. 
 
MATERIALS AND METHODS 
This study was approved by the Animal Care and Use 
Committee in our institution (Permit number: 13-0394-C1A1(3)). 
 
Animal Model 
New Zealand White rabbits weighing 3.0–3.5 kg, were 
selected for this study animal model. For the pilot study, four 
rabbits were included, and for the main study, eight rabbits were 
included. The rabbit VX2 tumor model was chosen for the following 
reasons; (a) it is a reliable transplantable tumor model that has not 
been well established in large animals (19), (b) rodents are too 
small in size to obtain reliable perfusion parameters with MR/PET, 
(c) many previous studies have employed the rabbit VX2 tumor 
model for DCE-MR imaging (20, 21), and (d) the preclinical animal 
 
 ４ 
experimental center of our institute periodically inoculates VX2 
cells into the thigh muscles of New Zealand White rabbits to 
maintain in vivo passages of VX2 cells, thus making the cells easily 
accessible for this study. 
Prior to tumor implantation, animals were sedated by 
intravenous injection of 5 mg/kg of a 1:1 combination of tiletamine 
hydrochloride and zolazepam (Zoletil; Virbac, Carros, France) and 
xylazine hydrochloride (Rompun 2%; Bayer Korea, Seoul, Korea). 
After anesthesia and shaving of the paravertebral area, 0.2 ml of a 
suspension of finely minced fresh VX2 tumor was implanted in the 
left paravertebral muscle at the level of heart, using 16-gauge 
Medicut needles under ultrasonographic guidance. The heart was 
required to be within the scan range in order to measure the arterial 
input function of dynamic MR/PET. One week after tumor 
implantation, ultrasonography examination was performed by one 
radiologist (K.H.L.) under the anesthesia to determine whether 
tumor implantation was successful. Two weeks after tumor 
implantation, the VX2 tumors were expected to be approximately 2 
cm along the longest dimension, appropriate for tumor perfusion 
imaging. Each rabbit was subjected to MR/PET (Biograph mMR, 
Siemens Healthcare, Erlangen, Germany) on two successive days, 
14 days after tumor implantation. All efforts were made to minimize 
 
 ５ 
the suffering of animals during tumor implantation and MR/PET. 
 
MR/PET  
Rabbits were anesthetized, and a 20-gauge intra-venous 
cannula (Medicut) was inserted into the right marginal ear vein 
before the start of MR/PET. The MR/PET acquisition protocol is 
illustrated in Figure 1. Simultaneous MR and PET image acquisition 
was performed 14 days after tumor implantation. For dynamic 
MR/PET, 0.2 mmol/kg gadoterate meglumine (Dotarem; Guerbet, 
Bloomington, IN, USA) and 111 MBq 13N-NH3 were hand injected 
simultaneously using three-way stopcocks, followed by 8 ml saline 
chaser. The total injection volume of MR and PET contrast media 
was made up to 2 ml by dilution with normal saline to maintain 
uniform concentration of MR contrast media at every examination. 
Contrast media was injected slowly over a 30-s duration. The total 
scan time was approximately 25 min. Separate MRI and PET image 
acquisition was performed 15 days after tumor implantation. After 
completion of PET, the rabbits were removed from the MR/PET 
scanner and placed back inside the scanner approximately 60 
minutes later. The animals were positioned on their back at the 
same level as the MRI table. The dose, volume and method of 
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injection of injection of MR and PET contrast media were 
maintained the same between simultaneous and separate imaging. 
However, during separate MR and PET, 2ml normal saline was hand 
injected simultaneously as the control. The total examination time 
for separate imaging was approximately 40 min. Scanning 
parameters for MRI and PET were maintained the same for 




Figure 1. Schematic drawing of the MR/PET acquisition protocol. 
Schematic drawing of the MR/PET acquisition protocol. (A) 
Simultaneous MR/PET acquisition and (B) Separate MR and PET 




To set-up MR/PET protocol, animal model and to train 
research assistants, a pilot study was performed using four rabbits. 
Two research assistants helped in animal care and transportation. 
VX2 tumor was implanted in the left paravertebral muscle of each 
rabbit. One week after tumor implantation, successful growth of 
VX2 tumors was confirmed in all four rabbits on ultrasonography. 
Four rabbits underwent MR/PET examination, 14 days after tumor 
implantation. In one rabbit, tumor was located at the posterior 
mediastinum. Therefore, efforts were made to locate the needle tip 
in the paravertebral muscle area during tumor implantation in the 
main study. Three rabbits died from air-embolism during the 
simultaneous 10-min dynamic MR/PET examination. It was 
assumed that air inside the three-way connectors might have 
caused air-embolism. Therefore, efforts were made to minimize the 
air inside the three-way connectors through flushing saline in the 
main study. The remaining one rabbit successfully underwent 
MR/PET and were sacrificed after the second MR/PET imaging 
session by intravenous injection of 5 ml potassium chloride while 
under deep anesthesia. However, this rabbit was not included for 
the analysis of main study because the DCE-MRI parameters had 




All MR images were acquired using dedicated head and body 
coils approved for MR/PET at the same time. T2-weighted imaging 
(T2WI) was performed with the following parameters: repetition 
time/echo time (TR/TE), 4100/87 ms; matrix size, 128 x 128; slice 
thickness, 3 mm; and field of view (FOV), 130 x 130 mm. Pre-T1-
weighted (T1W) images were acquired with a gradient echo 
sequence (GRE) called weighted volumetric interpolated breath-
hold examination (VIBE) at each of the four flip angles for T1 
mapping using the following parameters: TR/TE 4.4/1.1 ms; flip 
angles (α=2°, 5°, 10° and 15°); matrix size 128 x 128; slice 
thickness 3 mm; number of slices 20; and 130 x 130 mm. Using the 
VIBE sequence, DCE-MR images were obtained at 5 s of temporal 
resolution with the following parameters: TR/TE, 3.5/1.5 ms; flip 
angles (α=11°); matrix size 128 x 128; slice thickness, 3 mm; 
number of slices, 20; and FOV, 130 x 130 mm. The total acquisition 
time of dynamic scan including the first six phases of pre-contrast 
images was 10 min.  
 
Dynamic 13N-NH3 PET parameters  
We planned on examining two rabbits per synthesis of 13N-
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NH3 (up to 200mCi/cassette). Since the radioactivity of 
13N-NH3 
decreases at the time of second injection, the volume of 13N-NH3 
that corresponds to 111 MBq is greater than that at the time of first 
injection. Theoretically, if 200 mCi of 13N-NH3 can be synthesized 
per one cassette, and the volume of 13N-NH3 that corresponds to 
111 MBq at the time of second injection would be 1.2ml if the time 
interval between the MR/PET examination was 40 min. However, 
practically, the synthesis of 13N-NH3 does not occur in 100%, so 
that synthesized 13N-NH3 is usually less than 200 mCi. Therefore, 
the injection volume of contrast media was set as 2ml to consider 
the practically synthesized amount of 13N-NH3 per one cassette.  
An approximately 20-s T1W Dixon GRE image in the 
coronal plane was first acquired for attenuation correction. Then, 
the emission protocol of a 10-min dynamic scan (6 x 5 s 
[precontrast]); 12 x 5 s; 3 x 10 s; 6 x 30 s; 2 x 60 s; and 1 x 180 
s) was implemented. The 30-s precontrast phase was included to 
maintain uniformity between dynamic 13N-NH3 PET and DCE-MRI. 






One board-certified radiologist (K.H.L.), with four years of 
experience after board certification, measured the diameter of 
whole tumor, that of necrotic area, and the proportion of necrotic 
area on delayed phase images from simultaneous and separate 
examination in each rabbit, respectively. In addition, the same 
radiologist manually drew region-of-interests (ROIs) on the left 
ventricle and tumors on DCE-MR images using MRIcro 
(http://www.sph.sc.edu/comd/rorden/mricro.html). To derive 
individual arterial input function (AIF) curves, ROIs were drawn in 
the left ventricle in three or four different image slices in the peak 
arterial enhancement phase of imaging. The radiologist also 
manually drew ROIs on tumors by outlining the entire tumor 
boundary as delineated by contrast enhancement in all involved MR 
slices containing the tumor in one of the delayed phases in which 
tumor was appropriately enhanced.  
 
In-house software program development 
Two commercially available software programs, Tissue 4D 
and Nordic, did not provide the function of parameter calculation on 
the basis of the individual AIF with perfusion map on voxel-level. 
Therefore, we developed an in-house software program using 
customized matrix laboratory (MATLAB) scripts (The Mathworks 
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Inc., Natick, MA, USA) to generate Ktrans and K1 maps on ROI- and 
voxel-level from DCE-MRI and 13N-NH3 PET using individual AIF 
curves. For simultaneous image acquisition, the MR and PET data 
were resampled to match the image coordinates and dimensions. 
For separately acquired MR and PET images, registration was 
processed using SPM software (Statistical Parametric Mapping, 
SPM12). The details of the in-house software program are 
described below.  
 
1. Tumor perfusion parameters from DCE-MRI 
1) Pre-processing of T1 signals in DCE-MRI 
Baseline T1 signal was measured using pre-T1 images 
acquired at four different flip angles. Three-dimensional (3D) R10 
and S0 maps were calculated based on the Ernst formula (TE ≪ 





0 11 exp / sin












where “α” has four discrete values in this study (α = 
2°, 5°, 10°, and 15°). A linear least square method was used for 
calculation of the 3D R10 and S0 maps (22).  
2) Estimation of contrast agent concentration time curves 
Four-dimensional (4D; x, y, z, t) post-injection longitudinal 
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relaxation rate (R1(t)) maps were calculated for each dynamic 
phase using signal intensity data from the pre- and post-contrast 
T1W-GRE dynamic series:  
1 ( )
1( ) (1/ ) ln



























; 10 10exp( )E TR R   ; and S(0) and S(t) are the 
signal intensities of images in the 4D T1W-GRE dynamic series 
before and after contrast injection. 4D gadoterate meglumine 
concentration maps (x, y, z, t) in tissues [Ct(t)] were calculated 
from 4D R1(t) maps as follows: 
1 10 1( ) ( )tR t R r C t    
where r1 is the experimentally determined relaxivity of 
gadoterate meglumine and r1 = 4.5mM
−1s−1 (at 37℃).  
3) Determination of individual AIF 
For each patient, concentration maps in blood (Cb(t) maps) 
were calculated based on the ROI in the left ventricle. Concentration 
maps in the plasma (Cp(t) maps) were calculated from Cb(t) maps 














4) Parameter estimation for a given compartmental model 
3D perfusion parameter (Ktrans) maps were calculated from 
the Cp(t) and 4D C(t) maps using the single-tissue compartment 
modified Tofts model: 
( / )( )
0
( ) ( ) ( )trans e
t
K V t u
t trans p p pC t K C u e du v C t     
2. Tumor perfusion parameters from 13N-NH3 PET 
Perfusion parameters from 13N-NH3 PET were calculated 
using several different methods. First, they were quantified using a 
2-tissue (2TCM) or 1-tissue (1TCM) compartment model. 
Goodness-of-fit factors (the Akaike information criteria [AIC], 
Schwartz criteria [SC], and model selection [MSC] criteria) were 
calculated for comparison of 1TCM and 2TCM perfusion parameters. 
Second, at the ROI-level, perfusion parameters were estimated 
from a single time-activity curve (TAC) of ROI or by averaging the 
parameters of voxels within the ROI.  
1) Two-tissue compartment model (2TCM) 
As in the equation for DCE-MRI parameters, Ca(t) is the 
concentration of 13N- NH3 in arterial blood and Ct(t) is the 
concentration of tracer in tissues. This model, which assumes that 
13N in tissue is in a freely diffusible (Ce) (intra- and extravascular) 
or a metabolically trapped (Cm) state, can be expressed as:  
 
 15 
2 31 ( )
3 2
2 3
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Since the rate of diffusion of 13N- NH3 across the capillary 
wall is high, the rate constant K1 is an indicator of blood flow. To 
address the issues of spillover and partial-volume recovery, it was 
assumed that 
 t (1 ) ( ) ( )t a t a aC V C t V C t      
where ( )tC t  is the concentration of tracer in tissues; Va is a 
real number between 0 and 1; and (1− Va) is a regional estimate of 
the tissue partial-volume recovery coefficient. 13N-NH3 PET 
perfusion parameters (K1) were estimated using a generalized 
linear least square method (23). 
2) One-tissue compartment model (1TCM) 
This model assumes that 13N is present either in blood (Ca) 
or in tissues (Ct) and can be expressed as:  
1 2
( )




K C t k C t
dt
   
Using this model, 13N-NH3 PET perfusion parameters (K1, 
k2) were estimated using the linear least square method. 
 




The voxel resolutions of DCE-MRI and 13N-NH3 PET were 
1.03 × 1.03 × 3 mm and 1.4 × 1.4 × 1.4 mm, respectively. For 
voxel-wise comparison of Ktrans and K1, parametric map images 
from PET (K1 map) were re-sliced into the same resolution as 
those from DCE-MRI (Ktrans map) using SPM software. Thus, the 
TACs and input functions for both PET and MR images could be 
obtained at each tumor voxel using the same masking image. 
 
Objectives and Outcomes 
Primary objective was to compare the regression function 
between the simultaneous versus separate acquisition. Secondary 
objective was 1) to measure the correlation coefficients between 
Ktrans and K1, 2) to measure reproducibility of Ktrans and K1, 3) to 
explain the regression function of Ktrans and K1 from simultaneous 
imaging, and 4) to compare 1TCM vs 2TCM in quantitative 
measurement of tumor perfusion parameters from 13N-NH3 PET. 
Primary outcome was the regression function of Ktrans and K1. 
Secondary outcomes were Pearson’s correlation coefficients 
between Ktrans and K1, intra-class correlation coefficients (ICC) of 





All efforts were made to minimize radiation exposure during 
the experiments, by using MR-compatible syringe shield and by 
maintaining the distance from animals and ammonia syringes as far 
as possible. To maintain consistent injection rate of MR and PET 
contrast media and to minimize radiation exposure, injection through 
contrast media injector is better than manual injection. However, 
there has been no available commercial dual injector than can be 
used for MR/PET. Therefore, a study investigator (K.H.L.) had to 
manually inject MR and contrast media. Research assistants were 
also aware of radiation exposure while transporting the animals 
from MR/PET room to the waiting room, and tried to minimize 
radiation exposure by keeping the distance from animals and 
ammonia syringes as far as possible after transportation. 
 
Statistical Analyses 
Pearson’s correlation coefficients between Ktrans and K1 
were calculated. The adjusted correlation coefficients were 
calculated in ROI- and voxel-level by the method of Bland and 
Altman (24, 25) which accounts for the lack of independence among 
repeated measurements. Correlation coefficients were interpreted 
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as follows; 0–0.3, negligible; 0.3–0.5, low positive; 0.5–0.7, 
moderate positive; 0.7–0.9, high positive; and 0.9–1.0, very high 
positive correlation (26). The relationship between Ktrans and K1 
on ROI-level was analyzed using a linear/nonlinear regression 
function. Reproducibility of Ktrans and K1 between two successive 
days on ROI-level were estimated using ICC by two-way mixed-
effects analysis, and ICCs of individual consistency-of-agreement 
were interpreted as follows; 0–0.2, poor; 0.2–0.4, fair; 0.4–0.6, 
moderate; 0.6–0.8, good; and 0.8–1.0, excellent correlation. Data 
analyses were performed using the Stata software package (version 
14; Stata, College Station, Tex).  
 
RESULTS 
On ultrasonography, successful growth of VX2 tumors was 
confirmed in all eight rabbits, one week after tumor implantation 
(Figure 2). Therefore, all eight rabbits underwent MR/PET 
examination, 14 days after tumor implantation. Of the eight rabbits, 
one died from air-embolism during the 10-min dynamic MR/PET 
examination. The remaining seven rabbits successfully underwent 
MR/PET and were sacrificed after the second MR/PET imaging 
session by intravenous injection of 5 ml potassium chloride while 
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under deep anesthesia. Because of some error in storage of the raw 
data of two rabbits, the final analysis included only five rabbits. 
Representative MR/PET images from simultaneous and separate 
MR/PET acquisition are shown in Figure 3.   
 
 
Figure 2. An example of the ultrasonographic images. 
To examine rabbits in which tumor implantation was successful, 
ultrasonographic examination was done to confirm tumor growth 




Figure 3. An example of the MR and PET images. 
(A) Dynamic contrast-enhanced MR, (B) Dynamic 13N-NH3 PET, 
and (C) Fused MR/PET images with simultaneous MR/PET 
acquisition 14 days after tumor implantation. 
(D) Dynamic contrast-enhanced MR, (E) Dynamic 13N-NH3 PET, 
and (F) Fused MR/PET images with separate MR and PET 
acquisition at 15 days after tumor implantation. 
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Rabbit tumor characteristics 
VX2 tumors were successfully grown in all five rabbits. The 
long diameters of the tumors ranged from 2.3-2.9 cm (Table 1). 
The size of whole tumor, that of necrotic area, and the proportion of 
necrotic area was similar between the day 14 and day 15 (Table 2). 
The number of ROIs outlining the tumors ranged from 12 to 18 per 
rabbit (total, 71 ROIs). Ktrans and K1 values of tumors were 
calculated successfully using in-house software program. 
Representative arterial input function curves and parametric maps 
are shown in Figure 4. The mean ± standard deviation of Ktrans was 
0.062 ± 0.04 min-1 and 0.036 ± 0.02 min-1, with simultaneous 
and separate image acquisition, respectively. The mean ± standard 
deviation of K1 calculated by 1TCM was 0.339 ± 0.11 mL/min/g 
and 0.231 ± 0.16 mL/min/g, with simultaneous and separate image 
acquisition, respectively. The mean ± standard deviation of K1 
calculated by 2TCM was 0.365 ± 0.12 mL/min/g and 0.224 ± 




Table 1. Summary of tumor characteristics in five rabbits 
Rabbit 1 2 3 4 5 









] 0.142 ± 0.01 0.159 ± 0.01 0.168 ± 0.02 0.228 ± 0.02 0.280 ± 0.02 




] 0.475 ± 0.04  0.997 ± 0.10 1.147 ± 0.25 1.322 ± 0.18 1.178 ± 0.22 
 









] 0.045 ± 0.04 0.180 ± 0.04 0.168 ± 0.03 0.308 ± 0.04 0.132 ± 0.03 




] 0.436 ± 0.03  0.728 ± 0.14 1.467 ± 0.17 0.522 ± 0.10 0.970 ± 0.15 
  K1 (2TCM) [mL/min/g] 0.100 ± 0.06 0.162 ± 0.13 0.433 ± 0.18 0.195 ± 0.12 0.285 ± 0.14 
1TCM, 1-tissue compartment model 
2TCM, 2-tissue compartment model  
Data are presented as mean ± standard deviation. 
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Necrotic area  
size (mm) 
Necrotic area  
proportion (%) 
Protocol 
1 28 23 82 Simultaneous 
 
27 23 85 Separate 
2 30 27 90 Simultaneous 
 
31 28 90 Separate 
3 28 26 93 Simultaneous 
 
30 26 87 Separate 
4 25 21 84 Simultaneous 
 
27 22 81 Separate 
5 31 27 87 Simultaneous 
 





Figure 4. Parameteric maps of Ktrans and K1. 
(A) An representative ROI outlining the entire tumor boundary drawn by a board-certified radiologist on dynamic 
contrast-enhanced MRI.  
(B) Arterial input function curve and (C) Ktrans map from dynamic contrast-enhanced MRI.  
(D) Arterial input function curve and (E) K1 map from dynamic 
13N-NH3 PET using 1-tissue compartment model.
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Dynamic NH3 PET Modeling 
The AIC, SC, and MSC values of 1TCM and 2TCM are 
shown in Table 3. The 1TCM model was found to be more 
appropriate model, given its lower AIC and SC values and greater 
MSC values in comparison with those of the 2TCM model. 
 
Table 3. Goodness-of-fit parameters of the 1-tissue compartment 
model (1TCM) and 2-tissue compartment model (2TCM) in 13N-
NH3 PET 
  1TCM 2TCM 
Simultaneous scan 
  
AIC 382.0 ± 10.9 400.4 ± 40.4 
SC 386.0 ± 10.9 405.6 ± 40.4 
MSC 4.7 ± 0.4 4.1 ± 1.5 
Separate scan 
  
AIC 380.0 ± 33.9 397.7 ± 57.6 
SC 384.2 ± 33.9 402.9 ± 57.6 
MSC 5.2 ± 1.0 4.6 ± 1.5 
AIC, Akaike information 
SC, Schwartz criteria 
MSC, model selection criteria  




Correlation coefficients between Ktrans and K1  
Assuming a linear relationship, there was a positive 
correlation between MR (Ktrans) and PET (K1) perfusion parameters 
at the ROI- and voxel-levels (Table 4). At the ROI-level, MR and 
PET perfusion parameters exhibited moderate positive correlations 
with simultaneous (r = 0.54–0.57) and separate (r = 0.53–0.69) 
imaging. At the voxel-level, the two sets of parameters exhibited 
only negligible correlations with simultaneous (r = 0.24) and 
separate (r = 0.16–0.18) imaging.  
 
Table 4. Correlation coefficient between Ktrans and K1 with 








    1TCM 0.24 0.18 
    2TCM 0.24 0.16 
ROI-level analysis 
  
    Average of voxel parameters, 1TCM 0.55 0.65 
    Average of voxel parameters, 2TCM 0.57 0.58 
    Single TAC, 1TCM 0.54 0.69 
    Single TAC, 2TCM 0.56 0.53 
1TCM, 1-tissue compartment model 
2TCM, 2-tissue compartment model  
TAC, time-activity curve 
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Relationship between Ktrans and K1 
While the Ktrans and K1 from separate imaging exhibited a 
linear relationship, those from simultaneous imaging exhibited a 
nonlinear relationship (Figures 5, 6).  
 
The regression function which fitted in the scatterplot of the 
Ktrans and K1 obtained from simultaneous imaging was as follows, 
even though the value of R-squared was not fairly high. With 
simultaneous imaging, the amount of change in K1 associated with a 
unit increase in Ktrans varied depending on the values of Ktrans.  
1) 1TCM 
K1 = 0.1279 * ln (Ktrans) + 0.7166, R-squared: 0.4342 
2) 2TCM 
K1 = 0.1421 * ln (Ktrans) + 0.7841, R-squared: 0.4676 
 
The regression function which fitted in the scatterplot of the 
Ktrans and K1 obtained from simultaneous imaging was as follows, 
even though the value of R-squared was relatively small. With 
separate imaging, the amount of change in K1 associated with a unit 




K1 = 4.8089 * Ktrans + 0.0568, R-squared: 0.2321 
2) 2TCM 





Figure 5. Scatterplot of Ktrans versus K1 (K1 was calculated using 
1TCM). 
(A) Ktrans versus K1 from simultaneous MR/PET acquisition 
(B) Ktrans versus K1 from separate MR and PET acquisition.  







Figure 6. Scatterplot of Ktrans versus K1 (K1 was calculated using 
2TCM). 
(A) Ktrans versus K1 from simultaneous MR/PET acquisition 
(B) Ktrans versus K1 from separate MR and PET acquisition.  




Reproducibility of Ktrans and K1  
While the ICCs of Ktrans between simultaneous and separate 
imaging revealed fair agreement (ICC, 0.29-0.31), those of K1 
demonstrated moderate agreement (ICC, 0.44-0.49) (Table 5). 
 




] K1 [mL/min/g] 
Average of voxel parameters, 1TCM 0.29 0.46 
Average of voxel parameters, 2TCM 0.29 0.49 
Single TAC, 1TCM 0.31 0.44 
Single TAC, 2TCM 0.31 0.44 
1TCM, 1-tissue compartment model 





In this study, Ktrans and K1 exhibited moderate positive 
correlations with both simultaneous (r = 0.54–0.57) and separate (r 
= 0.53–0.69) imaging at the ROI-level, under the assumption of 
linear relationship between MR and PET parameters, as 
demonstrated with separate image acquisition. However, careful 
examination of the association between MR and PET parameters 
from simultaneous imaging revealed a nonlinear relationship 
between Ktrans and K1. The amount of change in K1 associated with a 
unit increase in Ktrans varied depending on the values of Ktrans. 
With simultaneous MR/PET examination, more robust 
investigation of the relationship between MR and PET perfusion 
parameters is possible than with separate acquisition. Simultaneity 
is one of the most powerful merits of hybrid MR/PET imaging in 
comparison with separate PET and MRI or PET/CT, which involves 
CT followed by PET, hoping that the subject does not move 
between the two procedures. However, hybrid MR/PET has not 
been thoroughly investigated, especially in terms of its ability to 
acquire in-vivo functional information, although its necessity has 
been recently suggested (3, 27). Simultaneous acquisition not only 
saves time but also enables better alignment quality (7) and precise 
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evaluation of the relationship between MR and PET parameters 
under identical tissue microenvironments.  
Validation of CT and MRI perfusion parameters has been 
performed mostly in brain and myocardial imaging (28, 29). Unlike 
perfusion imaging of the myocardium or the brain, there has been 
no established gold standard imaging method for tumor perfusion 
because of the possibility of tissue-dependent pathologic vascular 
abnormalities, such as vascular leakage, shunting, or malformation 
(30, 31). Instead, validation against histopathological findings such 
as microvessel density or vascular endothelial growth factors has 
been attempted for some tumors; however, the results were 
inconsistent and did not accurately reflect true tumor perfusion in 
vivo (32, 33). Furthermore, pathologic perfusion markers do not 
reflect perfusion in vivo. Therefore, investigation of the relationship 
between perfusion parameters from two different imaging 
modalities might serve to cross-validate each parameter. The 
present results indicate that Ktrans demonstrates a fair amount of 
blood flow, which is represented by K1. However, the amount of 
change in K1 associated with a unit increase in Ktrans was not always 
the same with simultaneous MR/PET acquisition, probably because 
Ktrans is influenced by both blood flow and permeability. Assuming 
the simple linear correlation between Ktrans and K1 based solely on 
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separate MR and PET images might result in misinterpretation of 
the relationship between the two sets of parameters. In our study, 
voxel-level analysis revealed only the negligible correlation 
between the two parameters. The limited resolution and blurring of 
PET images might explain this weak correlation on voxel-level and 
discrepancy between the voxel- and ROI-level analysis. 
While 13N-NH3 PET has been used in myocardial perfusion 
imaging, only a few studies have examined its utility in tumor 
imaging (15-18). Prior studies have demonstrated that 13N-NH3 
PET might be a useful imaging tool for semi-quantitative evaluation 
of tumor perfusion (15-17). Since this is the first study involving 
quantitative dynamic 13N-NH3 PET in tumor imaging, we estimated 
perfusion parameters using two different tissue-compartment 
models. Although the 2TCM has been widely used in myocardial 
perfusion, our data indicated that the 1TCM was more appropriate 
for tumor imaging. This difference might be attributable to the 
faster circulation time of rabbits, differences in microenvironments, 
and vascular abnormalities within the tumor.  
In the present study, the values of K1 (ICC, 0.44-0.49) 
were more reproducible than those of Ktrans (ICC, 0.29-0.31). 
Nonetheless, the overall reproducibility of K1 and Ktrans in this study 
was relatively low when compared to those reported in several 
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previous studies (34-36). Since the reproducibility of perfusion 
parameters may vary according to the calculation method (37, 38), 
we speculate that the low reproducibility observed in the present 
study could be associated with several factors including the one-
day gap between simultaneous and separate imaging, calculation of 
pre-T1 values, estimation of individual AIF or TACs, and manual 
contrast media injection. Indeed, recent studies have also 
demonstrated the low reproducibility of perfusion parameters which 
is comparable to our study (39, 40).  
There are some limitations to the present study. First, this 
study included a small number of rabbits. Second, we chose 13N-
NH3 as a perfusion marker instead of 
15H2O, which is regarded as 
the gold standard for in vivo estimation of perfusion in the 
myocardium and brain, for the following reasons: (a) in comparison 
15H2O, the longer half-life of 
13N-NH3 (10 min) enables more 
consistent radiotracer injection among the subjects; (b) the main 
purpose of this study was to compare simultaneous and separate 
MR/PET, rather than validation of DCE-MRI, and (c) 13N-NH3 PET 
has been under-investigated as a tumor perfusion marker. Third, 
only quantitative perfusion parameters of MR and PET were 
evaluated in this study. Due to the limited reproducibility of 
quantitative perfusion parameters, semiquantitative parameters 
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such as initial area under the gadolinium concentration-time curve 
might have provided additional information. Fourth, temporal 
resolution of 5 second was relatively slow to evaluate the perfusion 
parameters of small animals. Finally, since the volume of blood flow 
and permeability might vary among tumors, the relationship 
between K1 and Ktrans might also vary among different tumors. 
In conclusion, the relationship between Ktrans and K1 was 
different between simultaneous and separate MR/PET acquisition. 
The relationship between Ktrans and K1 may be mis-interpreted with 
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초   록 
서론: 본 연구는 토끼 VX2 종양을 이용하여 역동적 조영 증강 
자기공명영상과 역동적 암모니아 양성자방출단층촬영을 동시 촬영했을 
때와 분리 촬영했을 때의 Ktrans과 K1의 관계를 비교하기 위한 동물 
실험 연구임.  
방법: 8마리 토끼의 왼쪽 척추인접 근육에 VX2 종양을 심고 2주 후, 
이틀에 걸쳐 첫째날은 역동적 조영 증강 자기공명영상과 역동적 
암모니아 양성자방출단층촬영을 동시에 촬영하였고 이튿날에는 역동적 
조영 증강 자기공명영상과 역동적 암모니아 양성자방출단층촬영을 각각 
따로 촬영하였음. 관류지표 분석 프로그램을 자체 개발하여 역동적 조영 
증강 자기공명영상으로부터 종양의 Ktrans 값을, 역동적 암모니아 
양성자방출단층촬영으로부터 종양의 K1값을 계산하였음. Ktrans과 K1의 
관계를 피어슨 상관 계수와 회귀 함수를 이용하여 분석하였음. 
결과: 최종 5마리의 토끼가 분석에 포함되었음. Ktrans과 K1이 선형 
상관관계를 갖는다고 가정하면, 동시 촬영했을 때 (피어슨 상관 계수: r 
= 0.54–0.57) 와 분리 촬영했을 때 (피어슨 상관 계수: r = 0.53–0.69) 
모두에서 Ktrans과 K1은 중간 정도의 양의 상관 관계를 보였음. 그러나 
회귀 함수를 이용하여 Ktrans과 K1의 관계를 분석해 보았을 때, 분리 
촬영했을 때는 Ktrans과 K1이 선형 상관 관계를 보였지만 동시 촬영했을 
때는 Ktrans과 K1은 비선형 상관 관계를 보이고 있었음. 동시 촬영시, 
Ktrans 의 단위 증가에 따른 K1 의 변화량은 Ktrans 값에 따라 달라졌음. 
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결론: Ktrans과 K1 관계는 역동적 조영 증강 자기공명영상과 역동적 
암모니아 양성자방출단층촬영을 동시 촬영했을 때와 분리 촬영했을 때 
다르게 나타났음. Ktrans과 K1 관계는 역동적 조영 증강 자기공명영상과 
역동적 암모니아 양성자방출단층촬영의 분리 촬영에만 기반해서는 
그릇되게 해석될 수 있음. 
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